SCHEMBL11243873

SCHEMBL11243873

COc1ccc(COCCN)cc1

nearest known ligand 0.59

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.59
AGXT P21549 2/20 0.59
TAAR1 Q96RJ0 1/20 0.59
MAOB P27338 3/20 0.55
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
APP P05067 7/20 0.53
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
SLC6A4 P31645 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15532301 0.96 APP (0.57) IDO1AGXTTAAR1MAOBTDP1
SCHEMBL16321948 0.96 APP (0.57) IDO1AGXTTAAR1MAOBTDP1
SCHEMBL8499580 0.87 IDO1 (0.61) IDO1AGXTTAAR1MAOBTDP1
SCHEMBL10458631 0.84 APP (0.70) IDO1AGXTTAAR1MAOBTDP1
SCHEMBL28386429 0.83 IDO1 (0.63) IDO1AGXTTAAR1MAOBTDP1
SCHEMBL34413 0.83 IDO1 (0.67) IDO1AGXTTAAR1MAOBTDP1
SCHEMBL17230489 0.82 TDP1 (0.56) IDO1AGXTTAAR1MAOBTDP1
SCHEMBL12462062 0.82 TDP1 (0.56) IDO1AGXTTAAR1MAOBTDP1
Methoxymethane SCHEMBL28823290 0.81 IDO1 (0.64) IDO1AGXTTAAR1MAOBTDP1
Potassium SCHEMBL1477050 0.81 IDO1 (0.64) IDO1AGXTTAAR1MAOBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250215116-A1 ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-07-03 US disclosed
US-20250109090-A1 METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-04-03 US disclosed
EP-4530284-A1 METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT Koei Chemical Company, Limited (JP) 2025-04-02 EP disclosed
CN-119707822-A Method for producing onium salt and method for purifying onium salt 广荣化学株式会社 2025-03-28 CN disclosed
EP-4501914-A1 ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE Koei Chemical Company, Limited (JP) 2025-02-05 EP disclosed
US-20250034600-A1 ONIUM SALT COMPOSITIONS, METHODS FOR PRODUCING CELLULOSE HYDROLYSATES, ALCOHOLS AND/OR ORGANIC ACIDS IN THE PRESENCE OF ONIUM SALT COMPOSITIONS KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-01-30 US disclosed
EP-4497830-A1 ONIUM SALT COMPOSITIONS, METHODS FOR PRODUCING CELLULOSE HYDROLYSATES, ALCOHOLS AND/OR ORGANIC ACIDS IN THE PRESENCE OF ONIUM SALT COMPOSITIONS Koei Chemical Company, Limited (JP) 2025-01-29 EP disclosed
CN-119372264-A Onium salt composition, method for producing cellulose hydrolysate, and method for producing alcohol and/or organic acid 广荣化学株式会社 2025-01-28 CN disclosed
CN-119156376-A Onium salt, onium salt composition, liquid composition containing onium salt and polysaccharide, process for producing the same, and process for recovering polysaccharide 广荣化学株式会社 2024-12-17 CN disclosed
WO-2023189817-A1 ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE 広栄化学株式会社 2023-10-05 WO disclosed
EP-3103797-B1 2,5-DIOXOIMIDAZOLIDIN-1-YL-3-PHENYLUREA DERIVATIVES AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS ALLERGAN INC (US) 2019-04-10 EP disclosed
WO-2012142457-A2 MACROLACTAM COMPOUNDS AND METHODS FOR THE TREATMENT OF MALARIA THE BROAD INSTITUTE, INC. (US) 2012-10-18 WO disclosed
US-4322342-A Analgesic compounds ELI LILLY AND COMPANY (US) 1982-03-30 US disclosed
US-4259234-A OLIGOPEPTIDES FOR PARENTERAL ADMINISTRATION ELI LILLY AND COMPANY (US) 1981-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250109090-A1 METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT NOTUM, CA7, CROCC IDO1 2026/4885AGXT 80/4885TAAR1 1536/4885
US-20250034600-A1 ONIUM SALT COMPOSITIONS, METHODS FOR PRODUCING CELLULOSE HYDROLYSATES, ALCOHOLS AND/OR ORGANIC ACIDS IN THE PRESENCE OF ONIUM SALT COMPOSITIONS ADH5, ADH1C, AMY1A IDO1 1027/4885AGXT 37/4885TAAR1 564/4885
US-20250215116-A1 ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE ALG1, FUT5, NANS IDO1 2565/4885AGXT 267/4885TAAR1 3957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.